Sana Biotechnology (SANA) Non-cash Items (2021 - 2026)
Sana Biotechnology recorded quarterly Non-cash Items of $15.6 million in Q1 2026, up 9.82% quarter-over-quarter from $14.2 million in Q4 2025, and up 17.86% year-over-year from $13.2 million in Q1 2025.
Sana Biotechnology's Non-cash Items history runs 6 years deep, the most recent figure standing at $15.6 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 17.86% year-over-year to $15.6 million; the TTM figure through Mar 2026 stood at $15.6 million (up 17.86% YoY), while the FY2025 annual figure was $14.2 million, down 6.61% from the prior year.
- Non-cash Items came in at $15.6 million for Q1 2026 at Sana Biotechnology, up from $14.2 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $15.6 million in Q1 2026 to a low of $5.1 million in Q1 2022.
- A 5-year average of $11.7 million and a median of $13.2 million in 2024 frame the typical range for Non-cash Items.
- Across the five-year window, Non-cash Items surged 130.23% in 2022 and dropped 6.61% in 2025, its largest moves.
- Sana Biotechnology's Non-cash Items stood at $7.4 million in 2022, then surged by 66.91% to $12.4 million in 2023, then advanced by 22.98% to $15.2 million in 2024, then dropped by 6.61% to $14.2 million in 2025, then gained by 9.82% to $15.6 million in 2026.
- According to Business Quant data, Non-cash Items over the past three periods registered $15.6 million, $14.2 million, and $14.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sana Biotechnology | 890.09 Mn | 890.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.58 Mn |
| Mar 31, 2026 | 15.58 Mn |
| Dec 31, 2025 | 14.19 Mn |
| Dec 31, 2025 | 14.19 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Sep 30, 2025 | 14.19 Mn |
| Jun 30, 2025 | 13.69 Mn |
| Jun 30, 2025 | 13.69 Mn |
| Mar 31, 2025 | 13.22 Mn |
| Mar 31, 2025 | 13.22 Mn |
| Dec 31, 2024 | 15.19 Mn |
| Dec 31, 2024 | 15.19 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Sep 30, 2024 | 14.64 Mn |
| Jun 30, 2024 | 14.49 Mn |
| Jun 30, 2024 | 14.49 Mn |
| Mar 31, 2024 | 13.19 Mn |
| Mar 31, 2024 | 13.19 Mn |
| Dec 31, 2023 | 12.36 Mn |
| Dec 31, 2023 | 12.36 Mn |
| Sep 30, 2023 | 12.72 Mn |
| Sep 30, 2023 | 12.72 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Mar 31, 2023 | 9.56 Mn |
| Dec 31, 2022 | 7.40 Mn |
| Dec 31, 2022 | 7.40 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Sep 30, 2022 | 6.60 Mn |
| Jun 30, 2022 | 5.89 Mn |
| Jun 30, 2022 | 5.89 Mn |
| Mar 31, 2022 | 5.14 Mn |
| Mar 31, 2022 | 5.14 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Dec 31, 2021 | 3.22 Mn |
| Sep 30, 2021 | 2.87 Mn |
| Sep 30, 2021 | 2.87 Mn |
| Jun 30, 2021 | 2.70 Mn |
| Jun 30, 2021 | 2.70 Mn |
| Mar 31, 2021 | 2.32 Mn |
| Mar 31, 2021 | 2.32 Mn |